Alnylam Pharmaceuticals
ALNY
#635
Rank
C$46.21 B
Marketcap
$357.02
Share price
0.29%
Change (1 day)
76.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company